| __timestamp | Amphastar Pharmaceuticals, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 461543000 |
| Thursday, January 1, 2015 | 37065000 | 634806000 |
| Friday, January 1, 2016 | 41199000 | 661905000 |
| Sunday, January 1, 2017 | 43415000 | 610753000 |
| Monday, January 1, 2018 | 57564000 | 696328000 |
| Tuesday, January 1, 2019 | 68853000 | 715007000 |
| Wednesday, January 1, 2020 | 67229000 | 628116000 |
| Friday, January 1, 2021 | 60932000 | 628793000 |
| Saturday, January 1, 2022 | 74771000 | 649606000 |
| Sunday, January 1, 2023 | 73741000 | 746773000 |
| Monday, January 1, 2024 | 747184000 |
In pursuit of knowledge
In the ever-evolving world of pharmaceuticals, innovation is the key to staying ahead. BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc. have been at the forefront of this race, investing significantly in research and development (R&D) over the past decade. From 2014 to 2023, BioMarin's R&D spending has consistently outpaced Amphastar's, with BioMarin investing nearly 10 times more on average. In 2023, BioMarin allocated approximately $747 million to R&D, marking a 62% increase from 2014. Meanwhile, Amphastar's R&D expenditure grew by 160% over the same period, reaching around $74 million in 2023. This substantial investment underscores the companies' commitment to innovation, with BioMarin focusing on rare genetic diseases and Amphastar on generic and specialty pharmaceuticals. As the industry continues to evolve, these investments will likely play a crucial role in shaping the future of healthcare.
Johnson & Johnson or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Merck & Co., Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs BioMarin Pharmaceutical Inc.
Takeda Pharmaceutical Company Limited vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: BeiGene, Ltd. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: United Therapeutics Corporation and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How BioMarin Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How Alkermes plc and Amphastar Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Arrowhead Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Geron Corporation and Amphastar Pharmaceuticals, Inc.